All In Biotech

Drug Trial Radar · NCT01364675

Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects

Primary Prevention of Cardiovascular Disease in Pre-diabetic & Pre-hypertensive Subjects Using Multiple Risks Reduction Strategy: A Multi-center, Double-blind, Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Jun 2, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 8,900 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

8,900

Planned (sponsor's estimate)

Start

Jan 2012

Primary completion

Jul 2016

Study completion Dec 2016

Sponsor

Lead sponsor
Ramathibodi HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ubon Ratchathani Public Health Office, Thailand; National Health Security Office, Thailand; The Government Pharmaceutical Organization
First posted
Jun 2, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether treating pre-diabetic \& pre-hypertensive individuals using multiple drugs intervention (anti-hypertensive drugs (i.e., ACEI) plus anti-glycemic drug (i.e., metformin) plus anti-hyperlipidemic drug (statin)) would lower Cardiovascular Disease (CVD) events.

Conditions

  • Pre-diabetes
  • Pre-hypertension

Interventions

  • Metformin+Enalapril+SimvastatinDrug

    Poly-pill - composed of Metformin (500 mg), Enalapril (10 mg) and Simvastatin (10 mg) in single tablet given once daily after dinner for 4 years

  • Placebo tabletDrug

    Identical Placebo Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cardiovascular EventsTime frame: 4-year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ubon ratchathani Public Health Office

    Muang District, Changwat Ubon Ratchathani, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.